Thomas J Fahey   Professor of Surgery

  • +1 212 746 5130

Endocrine Oncology

Dr. Fahey's clinical and basic research has focused on endocrine and pancreatic cancer. He is the Director of the Laboratory of Surgical Endocrinology.

Translational and Clinical Research Projects:

-DOTA TOC, Cornell is one of two northeastern facilities offering Gallium-68 DOTATOC PET/CT imaging for carcinoid and neuroendocrine cancer patients

-Prospective Molecular Diagnosis for Thyroid Nodules, Our group is exploring a panel of micro-RNAs that can discriminate between benign and malignant indeterminate nodules. There is growing interest in adding preoperative molecular screening tests for markers such as BRAF, RAS, RET/PTC, and PAX8/PPAR; to improve the diagnostic accuracy of FNA for indeterminate nodules

-Molecular profiling of endocrine tumors, The goal of this study is to identify clinically relevant molecular markers of endocrine tumors, which primarily includes tumors of the thyroid gland, parathyroids, adrenal glands, and neuroendocrine tumors from within the gastrointestinal tract and pancreas

-Precision medicine cornell, Precision medicine is targeted, individualized care that is tailored to each patient based on his or her specific genetic profile and medical history

-Link between prostate protein and adrenal tumors provides new hope for rare cancer

-PSMA, The purpose of this study is to evaluate changes in tumor blood flow and disease response to the investigational agent, 177Lu-J591



Sort by

Selected publications


Sort by

Grants awarded

  • Determining a Molecular Profile of Pancreatic Neuroendocrine Tumors Obtained by Fine Needle Aspiration  awarded by New York Presbyterian Hospital Principal Investigator 2013 - 2014
  • Molecular Characterization of Metastatic Neuroendocrine Tumors of the Gastrointestinal Tract  awarded by Goldhirsh-Yellin Foundation Principal Investigator 2014 -
  • A Platform for Drug Discovery Targeting MEN1 in Pancreatic Neuroendocrine Tumors  awarded by New York Presbyterian Hospital Key Personnel 2013 - 2015
  • Selenium Supplementation Decreases Thyroid Cancer Growth in Humans through Upregulation of Cell Cycle Arrest Genes  awarded by National Cancer Institute Principal Investigator Subaward 2005 - 2006



Primary Email



Primary Affiliation

  • Weill Cornell Medical College, Cornell University